Quality of care in systemic lupus erythematosus: Application of quality measures to understand gaps in care

Journal of General Internal Medicine

Volumn 27, Issue 10, 2012, Pages 1326-1333

  Yazdany, Jinoos ^a   Trupin, Laura ^a   Tonner, Chris ^a   Dudley, R Adams ^a   Zell, Joann ^b   Panopalis, Pantelis ^c   Schmajuk, Gabriela ^a   Julian, Laura ^a   Katz, Patricia ^a   Criswell, Lindsey A ^a   Yelin, Edward ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Outcomes; Quality of health care; Studies; Systemic lupus erythematosus

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE DURATION; ETHNICITY; FEMALE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POVERTY; PROSPECTIVE STUDY; SELF REPORT; SOCIOECONOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS; TELECONSULTATION;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTHCARE DISPARITIES; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; YOUNG ADULT;

EID: 84866896694     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-012-2071-z     Document Type: Article

References (33)

1. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum. 2007;56(6):2092-2094.
2. Fessel WJ. Epidemiology of systemic lupus erythematosus. Rheum Dis Clin North Am. 1988;14(1):15-23.
3. Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15-25.
4. Maisonneuve P, Agodoa L, Gellert R, et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis. 2000;35(1):157-165.
5. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54(8):2550-2557.
6. Yazdany J, Tonner C, Trupin L, et al. Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Arthritis Res Ther. 2010;12(3):R84.
7. Demas KL, Keenan BT, Solomon DH, Yazdany J, Costenbader KH. Osteoporosis and Cardiovascular Disease Care in Systemic Lupus Erythematosus According to New Quality Indicators. Semin Arthritis Rheum. Apr 6 2010.
8. Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res (Hoboken). 2010;62(7):993-1001.
9. Bernatsky SR, Cooper GS, Mill C, Ramsey-Goldman R, Clarke AE, Pineau CA. Cancer screening in patients with systemic lupus erythematosus. J Rheumatol. 2006;33(1):45-49.
10. Yazdany J, Panopalis P, Gillis JZ, et al. A quality indicator set for systemic lupus erythematosus. Arthritis Rheum. 2009;61(3):370-377. PMCID: PMC2748348.
11. Yelin E, Trupin L, Katz P, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum. 2007;57(1):56-63.
12. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271-1277.
13. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum. 2008;59(1):136-143.
14. Karlson EW, Daltroy LH, Rivest C, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus. 2003;12 (4):280-286.
15. Medical Expenditure Panel Survey. Available at: http://www.meps.ahrq.gov/ mepsweb/. Accessed April 2, 2012.
16. Walter LC, Lindquist K, Nugent S, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465-473.
17. Fenton JJ, Cai Y, Weiss NS, et al. Delivery of cancer screening: how important is the preventive health examination? Arch Intern Med. 2007;167(6):580-585.
18. Landon BE, Schneider EC, Normand SL, Scholle SH, Pawlson LG, Epstein AM. Quality of care in Medicaid managed care and commercial health plans. JAMA. 2007;298(14):1674-1681.
19. Thompson JW, Ryan KW, Pinidiya SD, Bost JE. Quality of care for children in commercial and Medicaid managed care. JAMA. 2003;290 (11):1486-1493.
20. Zhang JX, Huang ES, Drum ML, et al. Insurance status and quality of diabetes care in community health centers. Am J Public Health. 2009;99 (4):742-747.
21. 2010 National Committee forQuality Assurance'sQuality Compass® Available at: http://www.ncqa.org/tabid/60/Default.aspx. Accessed April 12, 2012.
22. Schmajuk G, Yazdany J, Trupin L, Yelin E. Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus. Arthritis Care Res. 2010;62(3):386-392.
23. Yazdany J, Trupin L, Kaiser R, Schmajuk G, Gillis JZ, Schwarz EB. Contraceptive counseling and use in SLE: A gap in health care quality? (In press, Arthritis Care & Research, 2010).
24. Ward MM. Association between physician volume and in-hospital mortality in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52(6):1646-1654.
25. Ward MM. Hospital experience and mortality in patients with systemic lupus erythematosus. Arthritis Rheum. 1999;42(5):891-898.
26. Ward MM. Hospital experience and expected mortality in patients with systemic lupus erythematosus: a hospital level analysis. J Rheumatol. 2000;27(9):2146-2151.
27. Ward MM. Medical insurance, socioeconomic status, and age of onset of endstage renal disease in patients with lupus nephritis. J Rheumatol. 2007;34(10):2024-2027.
28. Ward MM, Odutola JJ. Inter-hospital transfers of patients with systemic lupus erythematosus: characteristics, predictors, and outcomes. J Rheumatol. 2006;33(8):1578-1585.
29. Mangtani P, Shah A, Roberts JA. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect. 2007;135(1):139-143.
30. Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(4):748-757.
31. Skull SA, Andrews RM, Byrnes GB, et al. Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine. 2007;25(25):4775- 4783.
32. Zimmerman RK, Raymund M, Janosky JE, Nowalk MP, Fine MJ. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine. 2003;21(13-14):1486-1491.
33. Fowles JB, Rosheim K, Fowler EJ, Craft C, Arrichiello L. The validity of self-reported diabetes quality of care measures. Int J Qual Health Care. 1999;11(5):407-412.